This Consortium of 7 clinical research sites will continue to study rare diseases of the airways that are associated with defective mucociliary clearance. These disorders involve chronic airways infection with resultant bronchiectasis. Over the past 4 years, this Consortium has made great progress in studies of variant CF, Primary Ciliary Dyskinesia (PCD), and pseudohypoaldosteronism. Major advances include: 1) improved diagnostic testing in PCD (nasal NO as screening test and development of clinical genetic tests);2) discovery of novel phenotypes (increased prevalence of heterotaxy and congenital heart disease reflecting mutations in PCD-causing genes), and 3) identification of novel therapeutic targets in PCD (many STOP mutations in PCD-causing genes, which could potentially be corrected by a novel small molecule, PTC124). In the next 5 years, this Consortium will complete two ongoing longitudinal studies in PCD infants, children, and adolescents, which are designed to determine the age of onset and rate of progression of lung disease, onset of respiratory infection and evolution of respiratory microbiology, and to help define outcome measures for interventional trials. The diagnostic protocol will be extended to include 300 patients with non- CF ("idiopathic") bronchiectasis, which will likely lead to identification of a variety of rare disorders, including PCD, immunodeficiency, and a1-antitrypsin deficiency. Patients with rare airway disorders frequently have sub-optimal treatment, because diagnosis is incorrect (or delayed), and treatment is not driven by evidence based medicine. The three key hypotheses of this proposal are that: 1) systematic evaluation of patients with rare airways diseases will yield more precise diagnoses, and lead to better diagnostics, including genetic testing;2) well-designed cross-sectional and longitudinal studies will provide insight into disease pathogenesis that will direct development of Clinical Practice Guidelines for these disorders;and 3)longitudinal studies and pilot projects will define outcome measures for future therapeutic studies in PCD. Taken together, the proposed work will lead to earlier diagnoses, improved care, and more effective therapeutic interventions for rare airway diseases. In the broader view, better definition of pathobiology and/or molecular etiologies of these disorders will enhance our understanding of normal airway defense mechanisms.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HL096458-09
Application #
8323918
Study Section
Special Emphasis Panel (ZRG1-HOP-Y (50))
Program Officer
Banks-Schlegel, Susan P
Project Start
2004-08-06
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
9
Fiscal Year
2012
Total Cost
$1,250,000
Indirect Cost
$224,895
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Daniels, M L A; Lowe, J R; Roy, P et al. (2015) Standardization and validation of a novel and simple method to assess lumbar dural sac size. Clin Radiol 70:146-52
Kim, Raymond H; A Hall, David; Cutz, Ernest et al. (2014) The role of molecular genetic analysis in the diagnosis of primary ciliary dyskinesia. Ann Am Thorac Soc 11:351-9
Lin, Jianfeng; Yin, Weining; Smith, Maria C et al. (2014) Cryo-electron tomography reveals ciliary defects underlying human RSPH1 primary ciliary dyskinesia. Nat Commun 5:5727
Horani, Amjad; Brody, Steven L; Ferkol, Thomas W (2014) Picking up speed: advances in the genetics of primary ciliary dyskinesia. Pediatr Res 75:158-64
Shapiro, Adam J; Weck, Karen E; Chao, Kay C et al. (2014) Cri du chat syndrome and primary ciliary dyskinesia: a common genetic cause on chromosome 5p. J Pediatr 165:858-61
Knowles, Michael R; Ostrowski, Lawrence E; Leigh, Margaret W et al. (2014) Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. Am J Respir Crit Care Med 189:707-17
Zariwala, Maimoona A; Gee, Heon Yung; Kurkowiak, Malgorzata et al. (2013) ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6. Am J Hum Genet 93:336-45
Knowles, Michael R; Daniels, Leigh Anne; Davis, Stephanie D et al. (2013) Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med 188:913-22
Fowler, Cedar J; Olivier, Kenneth N; Leung, Janice M et al. (2013) Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med 187:1374-81
Sears, Patrick R; Thompson, Kristin; Knowles, Michael R et al. (2013) Human airway ciliary dynamics. Am J Physiol Lung Cell Mol Physiol 304:L170-83

Showing the most recent 10 out of 23 publications